FDx Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,344
Closed -$315K 830
2022
Q1
$315K Buy
+9,344
New +$307K 0.01% 649
2021
Q4
Sell
-8,457
Closed -$296K 856
2021
Q3
$296K Sell
8,457
-1,139
-12% -$44.5K 0.01% 671
2021
Q2
$399K Sell
9,596
-217
-2% -$8.67K 0.01% 574
2021
Q1
$362K Buy
+9,813
New +$371K 0.01% 570
2019
Q1
Sell
-21,459
Closed -$695K 793
2018
Q4
$695K Buy
21,459
+1,127
+6% +$45.5K 0.06% 245
2018
Q3
$1.04M Buy
20,332
+877
+5% +$43.9K 0.04% 332
2018
Q2
$980K Buy
19,455
+1,650
+9% +$83.7K 0.04% 369
2018
Q1
$909K Buy
17,805
+1,420
+9% +$75.7K 0.03% 540
2017
Q4
$861K Sell
16,385
-2,796
-15% -$139K 0.02% 600
2017
Q3
$938K Buy
19,181
+6,144
+47% +$292K 0.03% 544
2017
Q2
$630K Buy
13,037
+3,679
+39% +$169K 0.02% 688
2017
Q1
$394K Buy
9,358
+2,905
+45% +$120K 0.01% 871
2016
Q4
$272K Buy
6,453
+946
+17% +$38.6K 0.01% 978
2016
Q3
$241K Sell
5,507
-90
-2% -$4.03K 0.01% 829
2016
Q2
$244K Buy
5,597
+51
+0.9% +$2.2K 0.01% 795
2016
Q1
$244K Buy
5,546
+714
+15% +$30.2K 0.01% 807
2015
Q4
$202K Buy
+4,832
New +$204K 0.01% 819
2015
Q3
Sell
-26,477
Closed -$1.1M 780
2015
Q2
$1.1M Sell
26,477
-1,323
-5% -$56.5K 0.05% 303
2015
Q1
$1.15M Sell
27,800
-8,531
-23% -$329K 0.03% 541
2014
Q4
$1.35M Sell
36,331
-8,263
-19% -$298K 0.08% 231
2014
Q3
$1.55M Sell
44,594
-35,367
-44% -$1.22M 0.1% 205
2014
Q2
$2.68M Sell
79,961
-7,307
-8% -$244K 0.18% 125
2014
Q1
$3.04M Buy
87,268
+3,380
+4% +$118K 0.25% 79
2013
Q4
$2.98M Sell
83,888
-10,410
-11% -$349K 0.3% 66
2013
Q3
$3.05M Sell
94,298
-1,612
-2% -$52.5K 0.36% 50
2013
Q2
$3.38M Buy
+95,910
New +$3.33M 0.45% 37

Other funds holding FMS

FDx Advisors's FMS Position: Q2 2022 in Review

FDx Advisors sold out of Fresenius Medical Care (FMS) in Q2 2022, closing a stake of 9,344 shares — an estimated $315K sold.

FDx Advisors first reported a position in FMS in Q2 2013 and held it in 26 quarters. The position peaked at $3.38M in Q2 2013. 166 funds tracked by Wall St. Rank hold FMS as of Q2 2022.

  • FDx Advisors reported no remaining Fresenius Medical Care position as of Q2 2022 after selling out during the quarter.
  • FDx Advisors sold 9,344 Fresenius Medical Care shares in Q2 2022, an estimated $315K.
  • FDx Advisors first reported a position in Fresenius Medical Care in Q2 2013 and held it in 26 quarters.
  • FDx Advisors's Fresenius Medical Care position peaked at $3.38M in Q2 2013.
  • 166 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2022.

Based on FDx Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.